Singapore
Dynamic Transplantation Surgeon and Medical Affairs leader with over 12 years of extensive experience in pharmaceutical R&D and medical affairs across Asia Pacific and global markets. Currently serving as the Regional Medical Lead at ViiV Healthcare, Adrian has a proven track record of driving innovative clinical programs, enhancing real-world evidence generation, and orchestrating successful medical education initiatives. He has been well recognized with his unique strategic partner capabilities including engaging key opinion leaders and stakeholders to deliver significant advancements in study enrolment and publication outputs in the medical community.
Effective data generation and communication to inform clinical practice. - Initiated phase 4 clinical studies and led critical progression reviews, achieving 100% study enrolment ahead of timelines. - Expanded real-world evidence (RWE) generation KOL network by 2.5 times, resulting in a 270% rise in annualized RWE publications. - Spearheaded digital innovation by introducing the first Veeva-integrated traceable material for the APAC region, achieving record high open (75%) and click-through (25%) rates.
Focusing on the therapeutic areas of Women’s health and Cardio-Metabolic disease. - Supported the hub team in searching, triaging, and evaluating in-licensing opportunities, and conducted due diligence assessments of potential assets. - Collaborated with the head of medical affairs to establish the Regional Therapeutic Area Review Committee (APAC-TARC), providing strategic guidance on data generation. - Facilitated the initiation of a collaborative study, resulting in a primary manuscript publication within two years.
Therapeutic area specialist for transplantation/ immunology and Infectious diseases. Responsible for Asia Oceania region. - Delivered oral presentations and defended new indication applications and retentions at meetings with Health Authorities and Agencies. - Served as the Asia and Oceania regional representative for the late-phase development of a new transplant/immunology product (Modigraf), bridging Phase 1 and Phase 3 trials. - Supported the development of 4 clinical studies and one health economic model published in the Journal of Comparative Effectiveness Research
Based in regional office, responsible for South East Asia Countries (including Taiwan, Hong Kong and ASEANS). Key functions include: Feasibility management, Identify external KOL and relationship management, Recruitment and retention strategy planing, Clinical operation support, Provide monitoring team guidance and training, Familiar with regional (safety) regulatory requirements, Medical reviews on Adverse Event.
Key functions include: Feasibility management, Identify external KOL and relationship management, Recruitment and retention strategy planing, Clinical operation support, Provide monitoring team guidance and training, Familiar with regional (safety) regulatory requirements, Medical reviews on Adverse Event.
Key functions include: Feasibility management (Compose feasibility questionnaire, Identify potential investigator, Assist in protocol development), Clinical operations (Medical reviews, Therapeutic area training and Trial related training). Presenter in Investigator Meeting, Site initiation visit and Study closed out meeting.